Mounjaro 00002-1506
Generic: Tirzepatide
Product NDC
00002-1506- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 13, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA215866
Need to source Mounjaro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tirzepatide | 2.5 mg/.5mL |
Drug Class
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]G-Protein-linked Receptor Interactions [MoA]
Packaging Options(2)
4 SYRINGE in 1 CARTON (0002-1506-61) / .5 mL in 1 SYRINGE
4 SYRINGE in 1 CARTON (0002-1506-80) / .5 mL in 1 SYRINGE (0002-1506-01)